[1] Su Baogen, Bao Zongbi, Xing Huabin, et al. Enantioseparation of paroxetine intermediate on an amylose-derived chiral stationary phase by supercritical fluid chromatography[J].Journal of Chromatography A, 2009, 1216 (26) : 5140-5146.[2] Mireia Segura, Lidia Roura, Rafael de, et al.Synthesis of the major metabolites of Paroxetine[J].Bioorganic Chemistry, 2003, 31(3): 248-258.[3] Carmela De Risi, Giulia Fanton, Gian P Pollini, et al.Recent advances in the stereoselective synthesis of trans-3,4-disubstituted-piperidines: Applications to (-)-paroxetine[J].Tetrahedron: Asymmetry, 2008, 19(2): 131-135.[4] Rossi R, Turchetta S, Donnarumma M.The process for the production of paroxetine: US, 6583287[P].2003-06-24.[5] Ali F E, Thomas M R.Process for the preparation of aryl-piperidine carbinols: EP,0223334[P].1991-07-10.[6] Manfred T Reetz.Biocatalysis in organic chemistry and biotechnology: Past, present, and future[J]. J. Am. Chem. Soc., 2013, 135(34): 12480-12496.[7] Zheng Gaowei,Xu Jianhe.New opportunities for biocatalysis: Driving the synthesis of chiral chemicals[J]. Curr. Opin. Biotechnol., 2011, 22(6): 784-792.[8] Ashraf Ghanem.Trends in lipase-catalyzed asymmetric access to enantiomerically pure/enriched compounds[J]. Tetrahedron, 2007, 63(8): 1721-1754.[9] Vicente Gotor-Fernandez, Rosario Brieva, Vicente Gotor. Lipases: Useful biocatalysts for the preparation of pharmaceuticals[J]. Journal of Molecular Catalysis B: Enzymatic, 2006, 40(3): 111-120.[10] Gonzalo de Gonzalo, Rosario Brieva, V1'ctor M Sa'nchez, et al.Enzymatic resolution of trans-4-(4-fluorophenyl)-3-hydroxymethylpiperidines, key intermediates in the synthesis of (-)-paroxetine[J].J.Org.Chem., 2001, 66(26): 8947-8953.[11] Gonzalo de Gonzalo, Rosario Brieva, V'ctor M Sa'nchez, et al.Anhydrides as acylating agents in the enzymatic resolution of an intermediate of (-)-paroxetine[J].J.Org.Chem., 2003, 68(8): 3333-3336.[12] Gonzalo de Gonzalo, Rosario Brieva, V'ctor M Sa'nchez, et al.Enzymatic alkoxycarbonylation reactions on the intermediate in the synthesis of (-)-paroxetine,trans-N-benzyloxycarbonyl-4-(4-fluorophenyl)-3-hydroxymethylpiperidine[J].Tetrahedron: Asymmetry, 2003, 14(12): 1725-1731.[13] Chen C S, Wu S H, Girdaukas G, et al.Quantitative analyses of the biochemical kinetic resolutions of enantiomers 2: Enzyme catalysed esterification in water-organic solvents biphasic systems[J].J.Am.Chem.Soc., 1987, 109(9): 2812-2817.[14] Xu Z F, Affleck R, Wangikar P, et al.Ransition state stabilization of subtilisins in organic media[J]. Biotechnol.Bioeng., 1994, 43(6): 515-520.[15] Colja Laane, Sjef Boeren, Kees Vos, et al.Rules for optimization of biocatalysis in organic solvents[J]. Biotechnol.Bioeng., 1987, 30(1): 81-87.[16] Tomasz Siódmiak, Debby Mangelings, Yvan Vander Heyden, et al.High enantioselective novozym 435-catalyzed esterification of (R,S)-flurbiprofen monitored with a chiral stationary phase[J]. Appl. Biochem.Biotechnol., 2015, 175(5): 2769-2785. |